SAPLAI : Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to 19-year-old High School Students in GuAdeloupe and La RéunIon

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-19
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

The goal of this clinical trial is to evaluate the feasibility of a contraception education program delivered by peers via social networks to high school students.

Our primary hypothesis is that the implementation of a peer-led contraceptive education program via social networks is a feasible approach in high schools on Reunion Island and Guadeloupe, as part of a before-and-after study.

Our secondary hypotheses concern the evaluation of adoption, exploratory efficacy (on knowledge, attitudes and practices), acceptability and fidelity of the peer-led education program via social networks among high school students in La Réunion and Guadeloupe.

Participants will :

* Participate in a focus group to explore their views and experiences regarding the value of a peer educator as a source of sexual and reproductive health information. * answer questionnaires on their knowledge of sexual health * A selected group (peer influencers): Create educational content (after a training period) on sexual health, and particularly contraception, to be broadcast on social networks. * Take note of the program distributed on the networks by the peer influencers (for 3 months) * Fill in questionnaires on their knowledge of sexual health, after the program.

Eligibility criteria

Qualifiers

HIGH SCHOOL STUDENTS

Young men and women aged between 15 and 19

Living in La Réunion or Guadeloupe

Enrolled in one of the selected vocational high schools and whose school principal agrees to take part in the program

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Creation of a contraception education program and post on social networks for high school students
  • Education program
  • Survey and questionnaires

Treatment groups

120 Participants
are divided into 2 treatment groups